BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7507157)

  • 1. Correlation between histologic features and glomerular permeability in membranous nephropathy and immunoglobulin A nephropathy.
    Ikegaya N; Nagase M; Honda N; Kumagai H; Hishida A
    J Lab Clin Med; 1994 Jan; 123(1):94-101. PubMed ID: 7507157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocytopenia and disease severity in IgA nephropathy.
    Lemley KV; Lafayette RA; Safai M; Derby G; Blouch K; Squarer A; Myers BD
    Kidney Int; 2002 Apr; 61(4):1475-85. PubMed ID: 11918755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features of membranous nephropathy coexisting with IgA nephropathy].
    Wang SX; Zou WZ; Yang L; Zhao MH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):171-4. PubMed ID: 17535683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of diurnal rhythms in glomerular permeability in patients with membranous nephropathy.
    Koopman MG; Arisz L
    Nephrol Dial Transplant; 1997; 12 Suppl 2():47-52. PubMed ID: 9269700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry.
    Ashizawa M; Miyazaki M; Abe K; Furusu A; Isomoto H; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
    Am J Kidney Dis; 2003 Jul; 42(1):76-86. PubMed ID: 12830459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranous nephropathy with crescents: a series of 19 cases.
    Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
    Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
    Carrie BJ; Myers BD
    Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of superimposed renal lesions of IgA and membranous nephropathy with diabetic nephropathy].
    Ishiyama T; Miura Y; Aoyagi R; Maruyama Y
    Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):931-8. PubMed ID: 1484412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in heparan sulfate correlate with increased glomerular permeability.
    Groggel GC; Stevenson J; Hovingh P; Linker A; Border WA
    Kidney Int; 1988 Feb; 33(2):517-23. PubMed ID: 2452273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permselectivity in thin membrane nephropathy.
    Thomas DM; Coles GA; Griffiths DF; Williams JD
    J Clin Invest; 1994 May; 93(5):1881-4. PubMed ID: 7514188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of glomerular basement membrane laminins in membranous glomerulonephritis.
    Fischer E; Mougenot B; Callard P; Ronco P; Rossert J
    Nephrol Dial Transplant; 2000 Dec; 15(12):1956-64. PubMed ID: 11096140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexisting Membranous Nephropathy and IgA Nephropathy.
    Nishida M; Kato R; Hamaoka K
    Fetal Pediatr Pathol; 2015; 34(6):351-4. PubMed ID: 26418809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Hanamura K; Tojo A; Kinugasa S; Asaba K; Onozato ML; Uozaki H; Fukayama M; Fujita T
    Hum Pathol; 2011 May; 42(5):649-58. PubMed ID: 21292302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of four types of primary glomeropathy by application of a decision forest to ultrasonic and laboratory characteristics.
    Zhao TC; Wu JY; Li RN; Li X
    Ultrasound Med Biol; 2014 Sep; 40(9):2310-6. PubMed ID: 24912371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of rheumatoid arthritis with various histological lesions of the kidney].
    Honma M; Toyoda M; Miyauchi M; Yamamoto N; Kimura M; Maruyama M; Nishina M; Yagame M; Endo M; Sakai H; Suzuki D
    Nihon Jinzo Gakkai Shi; 2006; 48(2):67-73. PubMed ID: 16541759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal histological changes in relation to renal function and urinary protein excretion in IgA nephropathy.
    Berg UB; Bohman SO; Widstam-Attorps U
    Arch Dis Child; 1991 May; 66(5):593-7. PubMed ID: 2039248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier.
    Friedman S; Jones HW; Golbetz HV; Lee JA; Little HL; Myers BD
    Diabetes; 1983 May; 32 Suppl 2():40-6. PubMed ID: 6086024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biophysical basis of hypofiltration in nephrotic humans with membranous nephropathy.
    Ting RH; Kristal B; Myers BD
    Kidney Int; 1994 Feb; 45(2):390-7. PubMed ID: 8164424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biomarkers in glomerular disease.
    Caliskan Y; Kiryluk K
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):205-16. PubMed ID: 24602470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.
    Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X
    Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.